Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis

Rationale: Cystic fibrosis, like primary ciliary dyskinesia, is an autosomal recessive disorder characterized by abnormal mucociliary clearance and obstructive lung disease. We hypothesized that genes underlying the development or function of cilia may modify lung disease severity in persons with cystic fibrosis. Objectives: To test this hypothesis, we compared variants in 93 candidate genes in both upper and lower tertiles of lung function in a large cohort of children and adults with cystic fibrosis with those of a population control dataset. Methods: Variants within candidate genes were tested for association using the SKAT‐O test, comparing cystic fibrosis cases defined by poor (n = 127) or preserved (n = 127) lung function with population controls (n = 3,269 or 3,148, respectively). Associated variants were then tested for association with related phenotypes in independent datasets. Results: Variants in DNAH14 and DNAAF3 were associated with poor lung function in cystic fibrosis, whereas variants in DNAH14 and DNAH6 were associated with preserved lung function in cystic fibrosis. Associations between DNAH14 and lung function were replicated in disease‐related phenotypes characterized by obstructive lung disease in adults. Conclusions: Genetic variants within DNAH6, DNAH14, and DNAAF3 are associated with variation in lung function among persons with cystic fibrosis.

[1]  Michael J Bamshad,et al.  Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project. , 2016, American journal of human genetics.

[2]  Katsushi Tokunaga,et al.  Phenome-wide association study maps new diseases to the human major histocompatibility complex region , 2016, Journal of Medical Genetics.

[3]  Brian T. Naughton,et al.  Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases , 2016, Nature Biotechnology.

[4]  S. Dutcher,et al.  Genetics and biology of primary ciliary dyskinesia. , 2016, Paediatric respiratory reviews.

[5]  L. Morgan,et al.  The impact of Primary Ciliary Dyskinesia on the upper respiratory tract. , 2016, Paediatric respiratory reviews.

[6]  M. Dransfield,et al.  Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. , 2016, Clinics in chest medicine.

[7]  M. Moustaki,et al.  Clinical spectrum of primary ciliary dyskinesia in childhood. , 2016, World journal of clinical pediatrics.

[8]  L. Leatherbury,et al.  DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia , 2016, PLoS genetics.

[9]  M. Brodlie,et al.  Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets , 2015, Thorax.

[10]  Eric J. Topol,et al.  Protective alleles and modifier variants in human health and disease , 2015, Nature Reviews Genetics.

[11]  J. Rommens,et al.  Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis , 2015, Nature Communications.

[12]  Andrew J. Oler,et al.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. , 2015, American journal of respiratory and critical care medicine.

[13]  Simon Lin,et al.  Application of clinical text data for phenome-wide association studies (PheWASs) , 2015, Bioinform..

[14]  M. Rieder,et al.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis , 2015, PLoS genetics.

[15]  Zhan Ye,et al.  Phenome-wide association studies (PheWASs) for functional variants , 2014, European Journal of Human Genetics.

[16]  Richard B. Vallee,et al.  Control of cytoplasmic dynein force production and processivity by its C-terminal domain , 2015, Nature Communications.

[17]  M. Rosenfeld,et al.  Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. , 2015, American journal of respiratory and critical care medicine.

[18]  D. Meyerholz,et al.  Origins of cystic fibrosis lung disease. , 2015, The New England journal of medicine.

[19]  D. Meyerholz,et al.  Origins of cystic fibrosis lung disease. , 2015, The New England journal of medicine.

[20]  Garry R. Cutting,et al.  Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.

[21]  E. Hoffman,et al.  Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis , 2014, Science.

[22]  G. Abecasis,et al.  Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.

[23]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[24]  S. Brody,et al.  Picking up speed: advances in the genetics of primary ciliary dyskinesia , 2013, Pediatric Research.

[25]  Richard D Emes,et al.  Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm , 2013, Journal of Medical Genetics.

[26]  L. A. Daniels,et al.  Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. , 2013, American journal of respiratory and critical care medicine.

[27]  Emily H Turner,et al.  Mutations in SPAG1 cause primary ciliary dyskinesia associated with defective outer and inner dynein arms. , 2013, American journal of human genetics.

[28]  M. Rosenfeld,et al.  Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. , 2013, American journal of human genetics.

[29]  H. Omran,et al.  DYX1C1 is required for axonemal dynein assembly and ciliary motility , 2013, Nature Genetics.

[30]  Kate S. Wilson,et al.  CCDC65 Mutation Causes Primary Ciliary Dyskinesia with Normal Ultrastructure and Hyperkinetic Cilia , 2013, PloS one.

[31]  J. Lupski,et al.  ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. , 2013, American journal of human genetics.

[32]  M. Rosenfeld,et al.  ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. , 2013, American journal of human genetics.

[33]  A. Gaggar,et al.  Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. , 2013, Chest.

[34]  Ivana V. Yang,et al.  Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis , 2013, Thorax.

[35]  L. Clarke,et al.  Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies , 2013, Respiratory Research.

[36]  B. Kerem,et al.  LRRC6 Mutation Causes Primary Ciliary Dyskinesia with Dynein Arm Defects , 2013, PloS one.

[37]  M. Rosenfeld,et al.  Mutations in CCDC39 and CCDC40 are the Major Cause of Primary Ciliary Dyskinesia with Axonemal Disorganization and Absent Inner Dynein Arms , 2013, Human mutation.

[38]  M. Drumm,et al.  Genetic Influences on Cystic Fibrosis Lung Disease Severity , 2013, Front. Pharmacol..

[39]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[40]  M. Rieder,et al.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.

[41]  M. Rieder,et al.  Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis , 2012, Nature Genetics.

[42]  A. Schier,et al.  CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms , 2012, Nature Genetics.

[43]  H. Mussaffi,et al.  Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia , 2012, Nature Genetics.

[44]  Stacey S. Cherny,et al.  Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets , 2011, Human Genetics.

[45]  M. Corey,et al.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies , 2011, Pediatric pulmonology.

[46]  Fred A. Wright,et al.  Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.

[47]  J. Berg,et al.  Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: Implications for application to clinical testing , 2011, Genetics in Medicine.

[48]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[49]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[50]  Margaret Rosenfeld,et al.  Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. , 2009, Contemporary clinical trials.

[51]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[52]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[53]  T. Corcoran,et al.  Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. , 2007, Proceedings of the American Thoracic Society.

[54]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[55]  E. Fisher,et al.  Genetic Analysis of the Cytoplasmic Dynein Subunit Families , 2006, PLoS genetics.

[56]  C. McCarty,et al.  Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. , 2005, Personalized medicine.

[57]  Michael R Knowles,et al.  Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.

[58]  Jonathan D. Campbell,et al.  Disease-specific reference equations for lung function in patients with cystic fibrosis. , 2005, American journal of respiratory and critical care medicine.

[59]  S. Batzoglou,et al.  Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.

[60]  G. Pazour,et al.  Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes , 2005, Journal of Medical Genetics.

[61]  Hitoshi Sakakibara,et al.  Recent progress in dynein structure and mechanism. , 2005, Current opinion in cell biology.

[62]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[63]  A. Togias,et al.  Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. , 2000, JAMA.

[64]  I. Mackay,et al.  Chronic sinusitis in cystic fibrosis. , 1994, Journal of the Royal Society of Medicine.